Eam Investors, LLC Beam Therapeutics Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$84.37 - $133.6 $1.72 Million - $2.73 Million	-20,440 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$64.12 - $128.71 $1.31 Million - $2.63 Million	20,440 New	20,440 $2.63 Million
Q1 2021 May 11, 2021	SELL	$71.28 - $120.75 $1.69 Million - $2.85 Million	-23,642 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$22.24 - $95.63 $525,798 - $2.26 Million	23,642 New	23,642 $1.93 Million

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.